Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

1 Reason I Wouldn't Buy This High-Yielding Dividend Stock


A high-yielding dividend stock can generate lots of dividend income for your portfolio. But that doesn't mean you should buy a stock only because of its yield. Dividends are never guaranteed and investors shouldn't assume they won't change or suddenly stop. Plus, it's also a good idea to invest in a growing company so that there's potential for the dividend to increase in the future.

Drugmaker (NASDAQ: VTRS) provides investors with a high payout, but I would avoid the stock for one big reason: It has a growth problem.

Viatris last reported earnings on May 8. For the first quarter, which ended on March 31, the company's net sales of $3.7 billion declined by 11% year over year. And even if you look at the operational change (which factors out the impact of foreign exchange), it still showed a 6% decrease from the prior-year period.

Continue reading


Source Fool.com

Viatris Inc. Aktie

11,14 €
0,22 %
Die Viatris Inc. Aktie verzeichnet heute einen leichten Gewinn von 0,22 %.

Like: 0
Teilen

Kommentare